id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-N-0555-0002,FDA,FDA-2011-N-0555,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: Extralabel Drug Use in Animals",Notice,General Notice,2011-11-16T05:00:00Z,2011,11,2011-11-16T05:00:00Z,,2012-03-24T19:34:43Z,2011-29477,0,0,0900006480f6d747
FDA-2011-N-0555-0001,FDA,FDA-2011-N-0555,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: Extra Label Drug Use in Animals",Notice,General Notice,2011-08-16T04:00:00Z,2011,8,2011-08-16T04:00:00Z,2011-10-18T03:59:59Z,2011-08-16T14:24:17Z,2011-20813,0,0,0900006480ee2157